E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, ...

In a trial, Gossamer Bio's PAH treatment candidate seralutinib reduced the resistance blood faces moving into the lungs over ...

Researchers at the Smidt Heart Institute at Cedars-Sinai have found that women with type 2 diabetes who are diagnosed with ...

Treatment of systolic hypertension in the elderly should be based on nonpharmacological measures and medical therapy if the systolic hypertension cannot be controlled by conservative therapy alone.

Intensive blood pressure control for adults with hypertension and high cardiovascular risk can reduce the risk of mild ...

RADNOR, Pa. - Mineralys Therapeutics , Inc. (NASDAQ:MLYS), a biopharmaceutical company specializing in the development of treatments for cardiovascular and kidney diseases, has announced the ...

The company was testing its therapy, cibotercept, in patients with pulmonary arterial hypertension (PAH ... was aiming to compete with Merck's PAH treatment (MRK.N), opens new tab Winrevair ...

The stages of hypertension include elevated, stage 1, stage 2 and hypertensive crisis. These readings are above 120/80 mm Hg.

Safety of a Potential New Treatment to Manage Complications from Sickle Cell Disease Apr. 11, 2024 — A drug approved to treat pulmonary arterial hypertension may be effective at managing ...

Monash University researchers have revealed how the gut—and what we eat—regulates high blood pressure, opening the door to ...

Shares in Keros Therapeutics fell sharply Wednesday morning after it said it halted trials of its treatment for pulmonary hypertension after finding adverse health effects in patients trialing the ...

Beyond blood pressure, Roblyer’s team is exploring how light can help track cancer treatment. In collaboration with Dr. Naomi ...